Skip to content
2000
Volume 6, Issue 3
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Background

The impressive and innovative efforts of scientists worldwide have played a pivotal role in shaping the development and production of COVID-19 vaccines, widely acknowledged as vital resources for pandemic control.

Objective

The primary aim of this investigation was to identify the prevailing effects linked to these vaccines, particularly considering their implications for human well-being.

Methods

An online survey was conducted in various cities in India, and a trial version of Qualtrics CoreXM software was implemented to prototype 22 questionnaires.

Results

After vaccination, respondents reported various health changes: skin issues (26.9%), eye problems (22.3%), gastrointestinal issues (22.8%), respiratory symptoms (12.5%), and mental health effects (2.9%). Among the 1,047 participants, 8.9% reported having had sexual intercourse, 11.3% of men and 7.3% of women. A further 17.9% were unsure: 19.7% of men, 13.7% of women, and 37.5% of those identifying as “other.” The majority (73.3%) reported no sexual experience: 68.9% of men, 78.8% of women, and 62.5% of “others”.

Conclusion

This study offers an extensive perspective on the vaccination situation in the northern region of India. It delves into the intricate demographic factors influencing vaccine acceptance and understanding potential side effects. These discoveries contribute substantially to the ongoing conversation regarding the COVID-19 vaccination and its various impacts on public health and societal welfare.

Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975289337240428021013
2024-05-06
2025-09-27
Loading full text...

Full text loading...

References

  1. YangL. LiuS. LiuJ. COVID-19: immunopathogenesis and Immunotherapeutics.Signal Transduct. Target. Ther.20205112810.1038/s41392‑020‑00243‑2 32712629
    [Google Scholar]
  2. DanielS.J. Education and the COVID-19 pandemic.Prospects2020491-2919610.1007/s11125‑020‑09464‑3 32313309
    [Google Scholar]
  3. KambojS. KambojR. KambojS. GuarveK. DuttR. Novel coronavirus 2019 outbreak: A global epidemic.Lett. Drug Des. Discov.202017121458146410.2174/1570180817999200802033916
    [Google Scholar]
  4. SahuK.K. MishraA.K. LalA. SahuS.A. BackI.F. India Fights Back: COVID-19 Pandemic.Heart Lung202049544644810.1016/j.hrtlng.2020.04.014 32527575
    [Google Scholar]
  5. WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations.Available from: https://www.who.int/news/item/07-05-2021-who-lists-additional-COVID-19-vaccination
  6. ManningM.L. GerolamoA.M. MarinoM.A. Hanson-ZalotM.E. Pogorzelska-MaziarzM. COVID-19 vaccination readiness among nurse faculty and student nurses.Nurs. Outlook202169456557310.1016/j.outlook.2021.01.019 33610324
    [Google Scholar]
  7. HolderJ. Tracking coronavirus vaccinations around the world.Available from: https://www.nytimes.com/interactive/2021/world/COVID-vaccinations-trackerhtml
  8. KambojS. KambojR. KambojS. An electronic evaluation of symptoms in people of India Post-COVID-19 vaccination.Curr. Drug Saf.2023181516110.2174/1574886317666220328154358 35346010
    [Google Scholar]
  9. KambojR. KambojS. JoginathA. An investigation on self-medication practice during the COVID-19 pandemic among the indian population.Curr. Drug Saf.202318222423210.2174/1574886317666220426091831 36029075
    [Google Scholar]
  10. VairaL.A. SalzanoG. FoisA.G. PiombinoP. De RiuG. Potential pathogenesis of ageusia and anosmia in COVID‐19 patients.Int. Forum Allergy Rhinol.20201091103110410.1002/alr.22593 32342636
    [Google Scholar]
  11. HabasK. NganwuchuC. ShahzadF. Resolution of coronavirus disease 2019 (COVID-19).Expert Rev. Anti Infect. Ther.202018121201121110.1080/14787210.2020.1797487 32749914
    [Google Scholar]
  12. YüceM. FiliztekinE. ÖzkayaK.G. COVID-19 diagnosis —A review of current methods.Biosens. Bioelectron.202117211275210.1016/j.bios.2020.112752 33126180
    [Google Scholar]
  13. KumarN. KhoraA. LoombaR. COVID-19 vaccination program for children: An electronic assessment of symptoms.Curr. Drug Saf.202323699971710.2174/1574886318666230331085630 36999717
    [Google Scholar]
  14. OchaniR. AsadA. YasminF. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.Infez. Med.20212912036 33664170
    [Google Scholar]
  15. PokhrelS. ChhetriR. A literature review on impact of COVID-19 pandemic on teaching and learning.Higher Education for the Future20218113314110.1177/2347631120983481
    [Google Scholar]
  16. MercerT.R. SalitM. Testing at scale during the COVID-19 pandemic.Nat. Rev. Genet.202122741542610.1038/s41576‑021‑00360‑w 33948037
    [Google Scholar]
  17. ThompsonM.G. BurgessJ.L. NalewayA.L. Prevention and attenuation of COVID-19 with the BNT162b2 and mRNA-1273 vaccines.N. Engl. J. Med.2021385432032910.1056/NEJMoa2107058 34192428
    [Google Scholar]
  18. FernandesQ. InchakalodyV.P. MerhiM. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines.Ann. Med.202254152454010.1080/07853890.2022.2031274 35132910
    [Google Scholar]
/content/journals/covid/10.2174/0126667975289337240428021013
Loading
/content/journals/covid/10.2174/0126667975289337240428021013
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): CoreXM software; COVID-19; epidemic; immunity; mRNA; Vaccine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test